These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization. Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578 [TBL] [Abstract][Full Text] [Related]
5. Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963 [TBL] [Abstract][Full Text] [Related]
6. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. Palacios AR; Rossi MA; Mahler GS; Vila AJ Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337 [TBL] [Abstract][Full Text] [Related]
7. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors. Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399 [TBL] [Abstract][Full Text] [Related]
9. Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery. Yang Y; Yan YH; Schofield CJ; McNally A; Zong Z; Li GB Trends Microbiol; 2023 Jul; 31(7):735-748. PubMed ID: 36858862 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in β-lactamase inhibitor chemotypes and inhibition modes. Li R; Chen X; Zhou C; Dai QQ; Yang L Eur J Med Chem; 2022 Nov; 242():114677. PubMed ID: 35988449 [TBL] [Abstract][Full Text] [Related]
11. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231 [TBL] [Abstract][Full Text] [Related]
12. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria. Davies DT; Everett M Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541 [TBL] [Abstract][Full Text] [Related]
13. Approaches for the discovery of metallo-β-lactamase inhibitors: A review. Shi C; Chen J; Kang X; Shen X; Lao X; Zheng H Chem Biol Drug Des; 2019 Aug; 94(2):1427-1440. PubMed ID: 30925023 [TBL] [Abstract][Full Text] [Related]
14. Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review. Cheng Q; Zeng P; Chi Chan EW; Chen S Curr Pharm Des; 2022; 28(44):3538-3545. PubMed ID: 36177630 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the development of β-lactamase inhibitors. Jalde SS; Choi HK J Microbiol; 2020 Aug; 58(8):633-647. PubMed ID: 32720096 [TBL] [Abstract][Full Text] [Related]
16. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases. Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066 [TBL] [Abstract][Full Text] [Related]
17. A close look onto structural models and primary ligands of metallo-β-lactamases. Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711 [TBL] [Abstract][Full Text] [Related]
18. Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain. Vázquez-Ucha JC; Alonso-Garcia I; Guijarro-Sánchez P; Lasarte-Monterrubio C; Álvarez-Fraga L; Cendón-Esteve A; Outeda M; Maceiras R; Peña-Escolano A; Martínez-Guitián M; Arca-Suárez J; Bou G; Beceiro A; Int J Antimicrob Agents; 2023 Apr; 61(4):106738. PubMed ID: 36736925 [TBL] [Abstract][Full Text] [Related]
19. An updated patent review of metallo-β-lactamase inhibitors (2020-2023). Denakpo E; Naas T; Iorga BI Expert Opin Ther Pat; 2023; 33(7-8):523-538. PubMed ID: 37737836 [TBL] [Abstract][Full Text] [Related]
20. Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organisms. Koenig C; Kuti JL Pharmacotherapy; 2024 Aug; 44(8):658-674. PubMed ID: 38949413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]